KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.83 $2.63 Friday, 26th Apr 2024 CGEN stock ended at $1.92. This is 1.05% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.74% from a day low at $1.86 to a day high of $1.98.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
Apr 26, 2024 $1.90 $1.98 $1.86 $1.92 326 170
Apr 25, 2024 $1.96 $2.02 $1.89 $1.90 266 566
Apr 24, 2024 $1.96 $1.99 $1.90 $1.91 164 547
Apr 23, 2024 $1.88 $2.02 $1.88 $1.98 237 668
Apr 22, 2024 $1.90 $1.96 $1.87 $1.89 201 936
Apr 19, 2024 $1.91 $1.97 $1.84 $1.90 325 090
Apr 18, 2024 $1.88 $1.96 $1.83 $1.88 308 846
Apr 17, 2024 $2.03 $2.04 $1.90 $1.90 371 579
Apr 16, 2024 $1.96 $2.05 $1.90 $2.03 451 043
Apr 15, 2024 $2.11 $2.19 $1.94 $1.96 749 027
Apr 12, 2024 $2.23 $2.25 $2.09 $2.13 388 381
Apr 11, 2024 $2.25 $2.27 $2.20 $2.26 244 600
Apr 10, 2024 $2.31 $2.33 $2.23 $2.26 278 734
Apr 09, 2024 $2.34 $2.40 $2.33 $2.36 152 036
Apr 08, 2024 $2.47 $2.47 $2.33 $2.33 194 450
Apr 05, 2024 $2.34 $2.51 $2.32 $2.42 365 001
Apr 04, 2024 $2.38 $2.47 $2.32 $2.32 321 989
Apr 03, 2024 $2.36 $2.44 $2.34 $2.43 145 597
Apr 02, 2024 $2.43 $2.43 $2.30 $2.34 346 760
Apr 01, 2024 $2.56 $2.57 $2.45 $2.47 241 550
Mar 28, 2024 $2.54 $2.63 $2.50 $2.58 285 076
Mar 27, 2024 $2.49 $2.58 $2.45 $2.54 309 713
Mar 26, 2024 $2.54 $2.56 $2.44 $2.50 214 982
Mar 25, 2024 $2.59 $2.67 $2.51 $2.53 294 037
Mar 22, 2024 $2.66 $2.67 $2.55 $2.64 232 393
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT